As of December 2024, Jafron Biomedical has a market cap of $3.33B. This makes Jafron Biomedical the world's 3638th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.27B | -7.92% |
2023 | $2.46B | -28.22% |
2022 | $3.43B | -41.89% |
2021 | $5.90B | -21.41% |
2020 | $7.51B | 79.37% |
2019 | $4.19B | 73.11% |
2018 | $2.42B | 30.18% |
2017 | $1.86B | -32.26% |
2016 | $2.74B | - |